Physician profile
Brandy Scott
NPI 1871263095
$962.13
in general payments reported to CMS, 2019-2025
19 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.14 · 2023: $157 · 2024: $448 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $938.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $198.46 | 2024-2025 | |
| Pfizer INC. | $106.24 | 2023-2025 | |
| Axsome Therapeutics, INC. | $82.03 | 2024-2025 | Auvelity |
| Abbott Laboratories | $74.04 | 2024-2025 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $63.25 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $60.07 | 2024 | Rybelsus, Ozempic, Wegovy |
| Dynavax Technologies Corporation | $57.51 | 2024-2025 | Heplisav-B |
| Phathom Pharmaceuticals, INC. | $54.49 | 2024 | Voquezna |
| Lilly USA, LLC | $43.90 | 2024-2025 | Jardiance, Zepbound, Mounjaro |
| Novartis Pharmaceuticals Corporation | $43.02 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $33.24 | 2024-2025 | Airsupra |
| Biohaven Pharmaceuticals, INC. | $23.14 | 2021 | |
| Sanofi Pasteur INC. | $22.05 | 2024 | |
| Exact Sciences Corporation | $21.97 | 2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.01 | 2023 | Synjardy, Jardiance, Glyxambi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.39 | 2023 | Belsomra |
| Glaxosmithkline, LLC. | $15.29 | 2025 | Shingrix |
| Kowa Pharmaceuticals America, INC. | $14.90 | 2025 | Zoryve |
| Teva Pharmaceuticals USA, INC. | $14.13 | 2024 | Ajovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.